Commentary on "Transparency and Trust in the European Pharmaceutical Sector'

被引：0

作者：

Breckenridge, Alasdair ^{[1
]}

机构：

[1] Univ Liverpool, Dept Pharmacol & Therapeut, Liverpool, Merseyside, England

来源：

关键词：

D O I：

10.1080/13669877.2015.1027079

中图分类号：

C [社会科学总论];

学科分类号：

03 ; 0303 ;

摘要：

引用

页码：1118 / 1119

页数：2

共 50 条

[31] Pharmaceutical Legislation Revision of the European drug monitoring is to bring more transparency and security
Spielberg, Petra
[J]. AKTUELLE UROLOGIE, 2011, 42 (01) : 25 - 26
[32] Transparency and the pharmaceutical industry
Bracewell, R. M.
[J]. JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH, 2014, 44 (04): : 268 - 268
[33] Technology, Transparency, and Trust
Pfleeger, Shari Lawrence
[J]. IEEE SECURITY & PRIVACY, 2014, 12 (06) : 3 - 5
[34] Transparency builds Trust
Graf, Kerstin
[J]. WOCHENBLATT FUR PAPIERFABRIKATION, 2013, 141 (06): : 353 - 353
[35] Trust through Transparency
Jakob, Thilo
Merk, Hans F.
[J]. ALLERGO JOURNAL, 2015, 24 (01) : 3 - 3
[36] Trust in the Age of Transparency
Peppers, Don
[J]. HARVARD BUSINESS REVIEW, 2012, 90 (10) : 21 - 21
[37] Transparency builds trust
Austin, LJ
[J]. HOSPITALS & HEALTH NETWORKS, 2004, 78 (04): : 10 - 10
[38] Trust, Transparency, and Complexity
Thakor, Richard T.
Merton, Robert C.
[J]. REVIEW OF FINANCIAL STUDIES, 2023, 36 (08): : 3213 - 3256
[39] A time for trust and transparency
不详
[J]. NATURE ASTRONOMY, 2021, 5 (02) : 107 - 107
[40] ASBESTOS TRUST TRANSPARENCY
Behrens, Mark A.
[J]. FORDHAM LAW REVIEW, 2018, 87 (01) : 107 - 124